Specify a stock or a cryptocurrency in the search bar to get a summary
Senseonics Holdings Inc
SENSSenseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland. Address: 20451 Seneca Meadows Parkway, Germantown, MD, United States, 20876-7005
Analytics
WallStreet Target Price
1.4 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SENS
Dividend Analytics SENS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SENS
Stock Valuation SENS
Financials SENS
Results | 2019 | Dynamics |